思创医惠(300078) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥235,156,485.53, a decrease of 39.09% compared to ¥386,055,693.36 in the same period last year[5] - The net loss attributable to shareholders was ¥76,663,823.76, representing a decline of 347.67% from a profit of ¥30,953,691.43 in the previous year[5] - The company reported a basic and diluted earnings per share of -¥0.09, down 325.00% from ¥0.04 in the same period last year[5] - Net profit for Q1 2023 was a loss of CNY 80,567,340.48, compared to a profit of CNY 29,120,333.27 in Q1 2022, indicating a significant decline[26] - The total comprehensive income for Q1 2023 was -85,664,791.57 CNY, compared to 32,450,227.88 CNY in Q1 2022, indicating a substantial decrease in overall performance[27] - Basic and diluted earnings per share for Q1 2023 were both -0.09 CNY, compared to 0.04 CNY in the same period last year, reflecting a downturn in profitability[27] Cash Flow - The net cash flow from operating activities improved to ¥48,334,123.98, a significant increase of 133.80% compared to a negative cash flow of ¥143,017,748.92 in the same period last year[5] - The operating cash flow for Q1 2023 was 48,334,123.98 CNY, a recovery from a negative cash flow of -143,017,748.92 CNY in the previous year[30] - The company reported cash inflows from operating activities totaling 317,208,994.01 CNY, slightly up from 310,194,960.39 CNY in the previous year[30] - The cash outflow from investing activities was 357,660,058.09 CNY, compared to 99,748,655.31 CNY in the same period last year, indicating increased investment expenditures[30] - The net cash flow from financing activities was -103,463,332.98 CNY, a significant drop from a positive cash flow of 166,912.16 CNY in Q1 2022[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,514,161,875.38, down 3.69% from ¥3,648,625,453.19 at the end of the previous year[5] - Total assets as of March 31, 2023, were CNY 3,514,161,875.38, down from CNY 3,648,625,453.19 at the beginning of the year, a decrease of 3.7%[23] - Total liabilities decreased to CNY 2,264,586,341.85 from CNY 2,317,463,787.14, a reduction of 2.3%[23] - The company’s total equity decreased to CNY 1,249,575,533.53 from CNY 1,331,161,666.05, a decline of 6.1%[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 50,256[10] - The top shareholder, Lu Nan, holds 7.26% of the shares, amounting to 62,739,500 shares[10] - As of March 31, 2023, the company's stock repurchase account held 33,464,340 shares, accounting for 3.87% of the total share capital[11] - The company reported a total of 88,310,537 shares under lock-up agreements, with specific release conditions for different shareholders[13] - The company’s major shareholders include individuals and entities with significant stakes, such as Zhang Lichun and Hangzhou Botai Investment Management Co., Ltd.[11] Investment and Guarantees - The company issued 8,167,260 convertible bonds with a remaining amount of RMB 816,726,000 as of March 31, 2023[19] - The total balance of guarantees provided by the company and its subsidiaries amounted to RMB 635.50 million, representing 48.45% of the latest audited net assets[20] - The company’s full subsidiary, Yihui Technology Co., Ltd., provided guarantees totaling RMB 380 million, which is 28.97% of the latest audited net assets[20] - The company completed the interest distribution for its convertible bonds, with a total interest payment of RMB 4,900,362 for the period[15] Operational Metrics - Total operating revenue for Q1 2023 was CNY 235,156,485.53, a decrease of 38.9% compared to CNY 386,055,693.36 in the same period last year[25] - Total operating costs for Q1 2023 were CNY 304,851,282.96, down from CNY 363,464,962.64, reflecting a reduction of 16.2%[26] - The company reported a significant increase in research and development expenses, totaling CNY 33,460,399.84, compared to CNY 31,781,348.68 in the previous year, an increase of 5.3%[26] Other Financial Metrics - The weighted average return on equity was -6.03%, a decrease of 7.44% from 1.41% in the previous year[5] - Cash and cash equivalents at the end of Q1 2023 were CNY 456,724,688.34, down from CNY 470,050,480.40 at the beginning of the year, a decrease of 2.3%[22] - Accounts receivable decreased to CNY 678,776,186.86 from CNY 746,901,150.03, a decline of 9.1%[22] - The company’s long-term investments decreased slightly to CNY 276,204,970.94 from CNY 281,335,036.35, a decline of 1.9%[22] - The company experienced a decrease in other comprehensive income attributable to the parent company, amounting to -5,520,604.79 CNY in Q1 2023, compared to 3,329,894.61 CNY in Q1 2022[27] - The company received 15,234,935.19 CNY in tax refunds during Q1 2023, an increase from 9,419,590.38 CNY in the previous year[30]